The aim of this study was to determine if features of body composition, assessed using computed tomography (CT) scans, may be predictive of dose–limiting toxicity (DLT) in patients undergoing neo–adjuvant chemotherapy for oesophago–gastric cancer. The influence of sarcopenia and DLT on overall survival was also evaluated.